PCN130 Dose-Dependent Relation between Metformin and the Risk of Hormone Receptor-Positive, HER2-Negative (HR+/HER2-) Breast Cancer Among Postmenopausal Women with Type-2 Diabetes
Soumya Chikermane(University of Houston), Magnus L. Johnson(University of Houston), Rajender R. Aparasu(University of Houston), Susan Abughosh(University of Houston), Meghana V. Trivedi(University of Houston), Manju Sharma(Jamia Hamdard)
Cited by 0
Related Papers
Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation
|Journal of Biological Chemistry|2002|303
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
|Breast Care|2013|200
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
|Proceedings of the National Academy of Sciences|2016|185